RVP's first-quarter 2026 sales decline as mix shifts and tariffs pressure pricing, prompting cost cuts and a push to expand domestic production.
Retractable Technologies posts revenue growth, but widening losses, tariff pressures and weak margins underscore ongoing operational challenges and uncertain demand.
Retractable Technologies reports improved third-quarter 2025 earnings driven by better margins, investment gains and a shift toward domestic production.
| Electronic Equipment, Instruments & Components Industry | Information Technology Sector | Thomas J. Shaw CEO | AMEX Exchange | 76129W105 CUSIP |
| US Country | 221 Employees | - Last Dividend | - Last Split | 4 May 2001 IPO Date |
Retractable Technologies, Inc. is a company focused on the innovation, production, and global distribution of safety syringes and other medical safety products. Founded in 1994, the company has established itself in the healthcare industry by offering solutions aimed at reducing the incidence of needlestick injuries among healthcare professionals. Retractable Technologies operates primarily out of Little Elm, Texas, serving the healthcare sectors across the United States, North and South America, and other international markets. The company has built a reputation for its commitment to safety and quality, distributing its products through a combination of general line and specialty distributors, international distribution partners, and a direct marketing network.